◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

AURINIA PHARMACEUTICALS INC.

CIK: 1600620 SIC: 2834
$283.06M
Revenue
$287.20M
Net Income
88.46%
Gross Margin
37.06%
Op. Margin
$182.50M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 20 of 15 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Q2 2021
(Jun 30, 2021)
Q1 2021
(Mar 31, 2021)
+ Total Revenue $77.11M $73.47M $70.01M $62.47M $59.87M $67.77M $57.19M $50.30M $45.09M $54.52M $41.49M $34.41M $28.43M $55.78M $28.19M $21.62M $23.40M $14.67M $6.62M $914.00K
Revenue Growth % (YoY) 28.8% 8.4% 22.4% 24.2% 32.8% 24.3% 37.8% 46.2% 58.6% -2.3% 47.2% 59.1% 21.5% 280.3% 325.8% 2266.0% nan% nan% nan% nan%
Cost of Revenue $8.80M $8.18M $7.12M $8.57M $5.55M $6.04M $8.91M $7.75M $5.39M $6.77M $1.56M $421.00K $1.36M $2.45M $1.60M $256.00K $481.00K $254.00K $308.00K $48.00K
+ Gross Profit $68.31M $65.29M $62.89M $53.89M $54.31M $61.74M $48.28M $42.55M $39.70M $47.75M $39.93M $33.99M $27.07M $53.33M $26.59M $21.37M $22.92M $14.41M $6.31M $866.00K
Gross Margin % 88.6% 88.9% 89.8% 86.3% 90.7% 91.1% 84.4% 84.6% 88.0% 87.6% 96.2% 98.8% 95.2% 95.6% 94.3% 98.8% 97.9% 98.3% 95.3% 94.7%
Operating Expenses $43.88M $43.72M $49.92M $40.62M $61.54M $56.02M $58.70M $63.56M $74.77M $70.78M $57.66M $63.99M $56.53M $65.28M $64.18M $59.51M $56.11M $65.02M $53.75M $51.46M
Research & Development $10.89M $8.44M $7.43M $5.74M $8.11M $3.05M $4.08M $5.55M $10.23M $13.61M $12.65M $13.16M $9.87M $10.97M $11.53M $12.62M $11.15M $20.07M $10.09M $9.83M
+ Operating Income $33.24M $29.75M $20.08M $21.85M $-1.67M $11.75M $-1.51M $-13.25M $-29.67M $-16.26M $-16.17M $-29.58M $-28.10M $-9.50M $-35.99M $-37.88M $-32.70M $-50.35M $-47.13M $-50.54M
Operating Margin % 43.1% 40.5% 28.7% 35.0% -2.8% 17.3% -2.6% -26.3% -65.8% -29.8% -39.0% -86.0% -98.8% -17.0% -127.7% -175.2% -139.7% -343.3% -712.0% -5529.9%
Interest Expense $1.05M $1.10M $1.12M $1.07M $1.15M $1.21M $1.20M $1.28M $1.31M $1.40M $65.00K - - - - - - - - -
Interest Income $3.50M $3.32M $3.19M $3.57M $3.99M $4.27M - - $4.57M - - - - - - - - - - -
Income Before Tax $35.69M $31.96M $22.16M $24.35M $1.17M $14.81M $1.48M $-10.01M $-26.42M $-13.15M $-12.13M $-25.77M $-25.19M $-8.04M $-35.51M $-37.62M $-32.60M $-50.25M $-46.99M $-50.37M
Income Tax Expense $-175.10M $411.00K $643.00K $1.00M $-256.00K $457.00K $756.00K $739.00K $459.00K $298.00K $-642.00K $436.00K $855.00K $954.00K $9.00K $10.00K $726.00K $8.00K $18.00K $8.00K
+ Net Income $210.79M $31.55M $21.51M $23.34M $1.43M $14.35M $722.00K $-10.75M $-26.88M $-13.45M $-11.49M $-26.21M $-26.05M $-8.99M $-35.52M $-37.63M $-33.32M $-50.26M $-47.01M $-50.38M
Net Margin % 273.4% 42.9% 30.7% 37.4% 2.4% 21.2% 1.3% -21.4% -59.6% -24.7% -27.7% -76.2% -91.6% -16.1% -126.0% -174.0% -142.4% -342.6% -710.1% -5511.9%
Basic EPS 1.57 0.24 0.16 0.17 0.01 0.10 0.01 -0.07 -0.18 -0.09 -0.08 -0.18 -0.18 -0.06 -0.25 -0.27 -0.25 -0.39 -0.37 nan
Diluted EPS 1.52 0.23 0.16 0.16 0.01 0.10 0.01 -0.07 -0.18 -0.09 -0.08 -0.18 -0.18 -0.06 -0.25 -0.27 -0.25 -0.39 -0.37 nan
Basic Shares Outstanding - 131.8M 134.9M 138.9M -296K 143.1M 143.3M 144.0M 151K 142.8M 142.8M 142.6M 84K 141.9M 141.7M 141.7M 1.3M 128.4M 128.2M -
Diluted Shares Outstanding - 136.0M 137.5M 143.2M 1.2M 145.7M 144.1M 144.0M 151K 142.8M 142.8M 142.6M 84K 141.9M 141.7M 141.7M 1.3M 128.4M 128.2M -
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Q2 2021
(Jun 30, 2021)
Q1 2021
(Mar 31, 2021)
Cash & Cash Equivalents $80.16M $72.89M $52.91M $66.11M $83.40M $36.63M $33.27M $63.91M $48.76M $45.56M $81.39M $88.33M $94.09M $85.34M $151.41M $131.64M $231.64M $57.59M $121.56M $156.59M
Inventory $45.69M $44.79M $46.50M $46.20M $39.23M $38.71M $38.85M $39.76M $39.70M $32.82M $33.16M $31.75M $24.75M $25.32M $25.86M $26.27M $19.33M $19.29M $17.38M $15.94M
Other Current Assets $1.08M $301.00K $665.00K $781.00K $1.13M $2.70M $6.98M $2.00M $1.03M $1.65M $1.21M $1.23M $1.33M $3.81M - - $796.00K - - -
Total Current Assets $491.97M $438.74M $408.97M $405.76M $446.60M $440.46M $409.67M $398.22M $424.80M $426.47M $415.91M $423.65M $442.54M $459.70M $453.19M $477.62M $513.32M $329.22M $349.69M $372.25M
Property Plant & Equipment $2.11M $2.27M $2.42M $2.58M $2.73M $2.89M $3.04M $3.20M $3.35M $3.50M $3.65M $3.84M $3.65M $3.76M $4.18M $4.33M $4.42M $4.55M $4.81M $4.76M
Intangible Assets $3.76M $3.90M $4.05M $4.16M $4.36M $4.51M $4.62M $4.76M $4.98M $5.26M $5.68M $6.10M $6.42M $6.84M $7.34M $7.88M $8.40M $8.93M $9.29M $9.85M
Other Non-current Assets $93.00K $93.00K $93.00K $823.00K $823.00K $868.00K $867.00K $1.50M $1.52M $1.52M $1.52M $13.36M $13.34M $13.05M $12.36M $11.84M $11.84M $11.84M $11.86M $11.86M
Total Assets $751.59M $527.53M $502.56M $504.85M $550.64M $549.36M $523.53M $516.63M $548.06M $555.01M $548.90M $451.76M $470.86M $488.29M $482.15M $506.90M $543.37M $360.07M $386.27M $417.08M
Accounts Payable $3.31M $2.21M $3.31M $4.22M $5.19M - - - $4.33M - - - - - - - - - - -
Accrued Liabilities $66.62M $49.54M $49.70M $42.35M $64.97M - - - $50.06M - - - - - - - - - - -
Deferred Revenue $3.72M $4.60M $5.50M $4.59M $11.00M $4.30M $4.37M $4.91M $4.81M $4.66M $3.23M $3.16M $3.15M - - - $190.00K - - -
Other Current Liabilities $2.48M $2.50M $2.54M $1.70M $1.53M $1.59M $1.16M $1.15M $2.39M $2.61M $2.09M $1.98M $2.03M $724.00K $1.29M $502.00K $4.64M $6.46M $2.37M $2.38M
Total Current Liabilities $93.72M $76.22M $78.27M $68.41M $97.76M $78.61M $76.90M $71.05M $77.19M $73.89M $61.66M $42.05M $46.11M $41.77M $34.63M $33.84M $40.65M $37.54M $29.32M $21.15M
Other Non-current Liabilities $6.70M - - - $11.11M $10.84M $10.94M $12.29M $10.91M $10.34M $8.71M $12.32M $12.17M $15.83M $16.32M $17.38M $15.95M $16.56M $16.87M $17.89M
Total Liabilities $170.26M $161.76M $167.26M $154.66M $173.17M $161.36M $158.91M $157.16M $170.11M $163.14M $156.61M $61.35M $65.42M $64.87M $58.38M $58.78M $64.28M $61.89M $54.01M $46.85M
Retained Earnings $-649.37M $-860.16M $-891.71M $-913.23M $-936.57M $-938.00M $-952.35M $-953.07M $-942.32M $-915.45M $-902.00M $-890.51M $-864.30M $-838.26M $-829.27M $-793.75M $-756.12M $-722.80M $-672.54M $-625.53M
Total Stockholders Equity $581.33M $365.77M $335.30M $350.19M $377.48M $388.00M $364.62M $359.48M $377.95M $391.88M $392.29M $390.41M $405.44M $423.43M $423.77M $448.12M $479.09M $298.17M $332.26M $370.23M
Total Liabilities & Equity $751.59M $527.53M $502.56M $504.85M $550.64M $549.36M $523.53M $516.63M $548.06M $555.01M $548.90M $451.76M $470.86M $488.29M $482.15M $506.90M $543.37M $360.07M $386.27M $417.08M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Q2 2021
(Jun 30, 2021)
Q1 2021
(Mar 31, 2021)
Net Income $210.79M $31.55M $44.86M $23.34M $1.43M $4.32M $722.00K $-10.75M $-26.88M $-51.15M $-11.49M $-26.21M $-26.05M $-8.99M $-35.52M $-37.63M $-33.32M $-50.26M $-97.39M $-50.38M
Depreciation & Amortization $4.86M $14.59M $9.72M $4.86M $4.86M - - - - - - - - - - - - - - -
Stock-based Compensation $6.73M $7.95M $2.03M $-3.41M $8.95M $22.65M $14.32M $5.74M $11.77M $33.54M $21.73M $9.47M $6.90M $25.40M $17.08M $7.02M $8.58M $22.67M $15.57M $7.82M
Change in Receivables $10.73M $-5.82M $3.55M $3.81M $61.00K $12.39M $1.43M $4.82M $-13.86M $24.46M $6.02M $5.56M $-28.28M $26.36M $2.76M $4.99M $5.60M $9.81M $4.42M $1.19M
Change in Inventory $897.00K $5.57M $7.28M $6.97M $514.00K $-991.00K $-852.00K $56.00K $6.88M $8.98M $8.40M $6.99M $614.00K $8.46M $7.95M $6.94M $278.00K $5.37M $3.45M $2.01M
Change in Payables $1.10M $-2.97M $-1.88M $-974.00K $-3.69M - - - - - - - - - - - - - - -
Operating Cash Flow $45.67M $89.99M $45.54M $1.30M $30.11M $14.27M $-2.75M $-18.60M $14.31M $-47.77M $-34.50M $-31.67M $10.45M $-89.98M $-74.62M $-46.75M $-25.92M $-131.77M $-91.52M $-53.54M
Purchases of Investments $182.03M $344.62M $237.41M $91.99M $84.69M $461.14M $318.13M $121.26M $144.29M $379.21M $256.44M $142.40M $120.81M $403.18M $232.96M $163.50M $96.13M $342.83M $216.99M $115.17M
Investing Cash Flow $-36.76M $3.99M $17.76M $31.03M $39.22M $39.00K $10.61M $49.23M $-6.26M $-449.00K $19.25M $24.86M $-3.02M $-57.61M $-7.40M $-53.02M $-5.49M $-98.38M $-65.58M $-67.25M
Stock Issued $355.00K $401.00K $401.00K - $381.00K - - - - - - - - - - - $196.74M - - -
Stock Repurchased - $98.16M $89.48M $46.92M $21.80M $18.43M $18.43M $12.30M - - - - - - - - - - - -
Financing Cash Flow $-1.89M $-104.22M $-93.73M $-49.34M $-23.05M $-26.05M $-23.32M $-15.05M $-5.58M $447.00K $2.78M $1.64M $688.00K $1.75M $1.75M $405.00K $205.72M $15.39M $6.31M $5.03M
Net Change in Cash $7.02M $-10.24M $-30.43M $-17.00M $46.29M $-11.73M $-15.47M $15.58M $2.48M $-47.77M $-12.46M $-5.17M $8.12M $-145.85M $-80.27M $-99.36M $174.31M $-214.76M $-150.79M $-115.76M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $73.47M - $205.94M -
Cost of Revenue $8.18M - $23.87M -
Operating Expenses $43.72M - $134.27M -
Research & Development $8.44M - $21.61M -
Operating Income $29.75M - $71.67M -
Interest Expense $1.10M - $3.28M -
Interest Income $3.32M - $10.07M -
Income Before Tax $31.96M - $78.47M -
Income Tax Expense $411.00K - $2.06M -
Net Income $31.55M $722.00K $76.41M -
Basic EPS 0.24 - 0.57 -
Diluted EPS 0.23 - 0.55 -
Basic Shares Outstanding $131.81M - $135.16M -
Diluted Shares Outstanding $136.01M - $138.96M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $72.89M -
Inventory $44.79M $39.23M
Other Current Assets $301.00K $1.13M
Total Current Assets $438.74M $446.60M
Property Plant & Equipment $2.27M $2.73M
Intangible Assets $3.90M $4.36M
Other Non-current Assets $93.00K $823.00K
Total Assets $527.53M $550.64M
Accounts Payable $2.21M $5.19M
Accrued Liabilities $49.54M $64.97M
Deferred Revenue $4.60M $11.00M
Other Current Liabilities $2.50M $1.53M
Total Current Liabilities $76.22M $97.76M
Total Liabilities $161.76M $173.17M
Retained Earnings $-860.16M $-936.57M
Total Stockholders Equity $365.77M $377.48M
Total Liabilities & Equity $527.53M $550.64M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $31.55M $722.00K $76.41M -
Depreciation & Amortization - - $14.59M -
Stock-based Compensation - - $7.95M -
Change in Receivables - - $-5.82M -
Change in Inventory - - $5.57M -
Change in Payables - - $-2.97M -
Operating Cash Flow - - $89.99M -
Purchases of Investments - - $344.62M -
Investing Cash Flow - - $3.99M -
Stock Issued - - $401.00K -
Stock Repurchased - - $98.16M -
Financing Cash Flow - - $-104.22M -
Net Change in Cash - - $-10.24M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...